US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Alumis Inc.

29.39

+1.314.67%

Post-market: 28.81-0.5800-1.97%19:55 EST

Volume:1.09M

Turnover:32.26M

Market Cap:3.59B

PE:-7.62

High:30.03

Open:28.87

Low:28.64

Close:28.08

52wk High:30.60

52wk Low:2.76

Shares:122.00M

Float Shares:77.49M

Volume Ratio:0.71

T/O Rate:1.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-3.8545

EPS(LYR):-10.3816

ROE:-66.88%

ROA:-61.46%

PB:9.32

PE(LYR):-2.83

Loading ...

Overview Company News Filings

Alumis Inc - Climb Bio Refuses to Pay $3,000,000 Development Milestone Payment Due Jan 1, 2026 - SEC Filing

THOMSON REUTERS

Climb Bio Sues Alumis Over $3 Million Milestone Dispute

Assessing Alumis (ALMS) Valuation After S&P Pharma Index Inclusion and Reinforced Analyst Optimism

Simply Wall St.

Alumis Is Maintained at Buy by HC Wainwright & Co.

Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares

Assessing Alumis (ALMS) Valuation After Director Srinivas Akkaraju’s $2 Million Insider Share Purchase

Simply Wall St.

Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares

Alumis Inc. unveils late-stage immunology pipeline and key upcoming clinical milestones

Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares

Foresite Capital Management VI LLC Acquires Common Shares of Alumis Inc

Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc

Foresite Labs Reports Acquisition of Alumis Inc. Common Shares

Stock Track | Alumis Inc. Soars 13.07% in Pre-market on Wave of Insider and Institutional Share Acquisitions

Stock Track | Alumis Inc. Skyrockets 13.07% Following Significant Insider and Institutional Share Acquisitions

Stock Track | Alumis Inc. Soars 7.61% Pre-market Following Multiple Insider Share Acquisitions

Stock Track | Alumis Inc. Soars 7.61% Pre-market on Multiple Insider and Institutional Share Acquisitions

Foresite Labs LLC Reports Acquisition of Common Shares of Alumis Inc

Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc

Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares

Alumis Q3 Operating Expenses USD 117.358 Million

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ALMS/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ALMS","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","market":"US","secType":"STK","nameCN":"Alumis Inc.","latestPrice":29.39,"timestamp":1772053200000,"preClose":28.08,"halted":0,"volume":1091602,"hourTrading":{"tag":"盘后","latestPrice":28.81,"preClose":29.39,"latestTime":"19:55 EST","volume":33724,"amount":990704.0743,"timestamp":1772067340691,"change":-0.58,"changeRate":-0.019735,"amplitude":0.019735},"delay":0,"changeRate":0.046652421652421734,"floatShares":77486300,"shares":122000000,"eps":-3.8545,"marketStatus":"Not Yet Opened","change":1.31,"latestTime":"02-25 16:00:00 EST","open":28.865,"high":30.03,"low":28.635,"amount":32256954.809812,"amplitude":0.049679,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.8545,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1772096400000},"marketStatusCode":0,"adr":0,"listingDate":1719547200000,"exchange":"NASDAQ","adjPreClose":28.08,"preHourTrading":{"tag":"盘前","latestPrice":28.92,"preClose":28.08,"latestTime":"09:29 EST","volume":122,"amount":3505.96951,"timestamp":1772029799961,"change":0.84,"changeRate":0.029915,"amplitude":0.057518},"postHourTrading":{"tag":"盘后","latestPrice":28.81,"preClose":29.39,"latestTime":"19:55 EST","volume":33724,"amount":990704.0743,"timestamp":1772067340691,"change":-0.58,"changeRate":-0.019735,"amplitude":0.019735},"volumeRatio":0.710553,"impliedVol":0.9611,"impliedVolPercentile":0.2579},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ALMS\",,,,,undefined,":{"symbol":"ALMS","floatShares":77486300,"roa":"-61.46%","roe":"-66.88%","lyrEps":-10.381567,"volumeRatio":0.710553,"shares":122000000,"dividePrice":0,"high":30.03,"amplitude":0.049679,"preClose":28.08,"low":28.635,"week52Low":2.7601,"pbRate":"9.32","psRate":"162.09","week52High":30.6,"institutionHeld":0,"latestPrice":29.39,"eps":-3.8545,"divideRate":0,"volume":1091602,"delay":0,"ttmEps":-3.8545,"open":28.865,"prevYearClose":9.76,"prevWeekClose":27.97,"prevMonthClose":24.51,"prevQuarterClose":9.76,"fiveDayClose":27.51,"twentyDayClose":26,"sixtyDayClose":7.64},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ALMS\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-11-13","symbol":"ALMS","fiscalQuarterEnding":"2025/09","expectedEps":-0.92,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-1.06},{"market":"US","date":"2025-08-13","symbol":"ALMS","fiscalQuarterEnding":"2025/06","expectedEps":-1.11,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-1.17},{"market":"US","date":"2025-05-14","symbol":"ALMS","fiscalQuarterEnding":"2025/03","expectedEps":-1.47,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1747195200000,"reportTimeType":"post","actualEps":-1.82},{"market":"US","date":"2025-03-19","symbol":"ALMS","fiscalQuarterEnding":"2024/12","expectedEps":-1.39,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-11-13","symbol":"ALMS","fiscalQuarterEnding":"2024/09","expectedEps":-1.64,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-1.73}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ALMS\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ALMS\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5556,"buy":0.4444,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5556,"analysts":9,"updateTime":1753765200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ALMS\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ALMS","date":"2026-02-24","current":-7.624854,"percent":0.007212,"low":-14.850306,"twenty":-3.708544,"median":-2.081121,"eighty":-0.973379,"high":-0.443678,"avg":-3.001685,"sd":3.093859,"marketCap":3446756068},"quantilePoints":[{"date":"2024-06-28","current":-4.084559,"twenty":-4.913756,"median":-4.913756,"eighty":-4.416238,"marketCap":689534895},{"date":"2024-07-05","current":-3.516406,"twenty":-4.747917,"median":-3.851156,"eighty":-3.59564,"marketCap":593622147},{"date":"2024-07-12","current":-3.405847,"twenty":-4.063676,"median":-3.825051,"eighty":-3.58397,"marketCap":574958044},{"date":"2024-07-19","current":-4.023985,"twenty":-4.026561,"median":-3.851156,"eighty":-3.52869,"marketCap":679309112},{"date":"2024-07-26","current":-4.023985,"twenty":-4.117224,"median":-3.947896,"eighty":-3.58397,"marketCap":679309112},{"date":"2024-08-02","current":-4.178507,"twenty":-4.123137,"median":-3.980142,"eighty":-3.620209,"marketCap":705394582},{"date":"2024-08-09","current":-3.850149,"twenty":-4.108328,"median":-3.938677,"eighty":-3.693301,"marketCap":649962958},{"date":"2024-08-16","current":-3.683794,"twenty":-4.085032,"median":-3.914533,"eighty":-3.659692,"marketCap":696362265},{"date":"2024-08-23","current":-3.672282,"twenty":-4.078883,"median":-3.855481,"eighty":-3.667968,"marketCap":694186133},{"date":"2024-08-30","current":-3.655014,"twenty":-4.050383,"median":-3.84693,"eighty":-3.659692,"marketCap":690921935},{"date":"2024-09-06","current":-3.442045,"twenty":-4.027205,"median":-3.798947,"eighty":-3.608967,"marketCap":650663491},{"date":"2024-09-13","current":-3.33556,"twenty":-4.023985,"median":-3.741353,"eighty":-3.511116,"marketCap":630534270},{"date":"2024-09-20","current":-3.301025,"twenty":-4.023985,"median":-3.709695,"eighty":-3.405847,"marketCap":624005873},{"date":"2024-09-27","current":-3.211808,"twenty":-3.980142,"median":-3.685233,"eighty":-3.395997,"marketCap":607140850},{"date":"2024-10-04","current":-2.803137,"twenty":-3.959602,"median":-3.672282,"eighty":-3.303903,"marketCap":529888161},{"date":"2024-10-11","current":-2.978693,"twenty":-3.946725,"median":-3.656453,"eighty":-3.263611,"marketCap":563074175},{"date":"2024-10-18","current":-3.462191,"twenty":-3.930629,"median":-3.608967,"eighty":-3.220442,"marketCap":654471723},{"date":"2024-10-25","current":-3.424777,"twenty":-3.915649,"median":-3.608753,"eighty":-3.22332,"marketCap":647399293},{"date":"2024-11-01","current":-3.254977,"twenty":-3.914533,"median":-3.516406,"eighty":-3.231953,"marketCap":615301345},{"date":"2024-11-08","current":-3.459313,"twenty":-3.86344,"median":-3.50536,"eighty":-3.240587,"marketCap":653927690},{"date":"2024-11-15","current":-2.016571,"twenty":-3.859807,"median":-3.465068,"eighty":-3.22332,"marketCap":481504843},{"date":"2024-11-22","current":-2.155567,"twenty":-3.851156,"median":-3.454996,"eighty":-3.18015,"marketCap":514693313},{"date":"2024-11-29","current":-2.109995,"twenty":-3.85035,"median":-3.444923,"eighty":-3.067334,"marketCap":503811848},{"date":"2024-12-06","current":-2.050751,"twenty":-3.847574,"median":-3.439167,"eighty":-2.978693,"marketCap":489665943},{"date":"2024-12-13","current":-1.911755,"twenty":-3.823752,"median":-3.419021,"eighty":-2.94646,"marketCap":456477473},{"date":"2024-12-20","current":-2.009736,"twenty":-3.802749,"median":-3.405847,"eighty":-2.329653,"marketCap":479872624},{"date":"2024-12-27","current":-1.836561,"twenty":-3.764391,"median":-3.395997,"eighty":-2.153744,"marketCap":438523055},{"date":"2025-01-03","current":-1.925427,"twenty":-3.741353,"median":-3.367218,"eighty":-2.142807,"marketCap":459741913},{"date":"2025-01-10","current":-1.595028,"twenty":-3.741353,"median":-3.312536,"eighty":-2.023407,"marketCap":380851289},{"date":"2025-01-17","current":-1.745417,"twenty":-3.740777,"median":-3.298147,"eighty":-1.989684,"marketCap":416760124},{"date":"2025-01-24","current":-1.522113,"twenty":-3.738475,"median":-3.27944,"eighty":-1.964163,"marketCap":363440944},{"date":"2025-01-31","current":-1.704402,"twenty":-3.735597,"median":-3.263611,"eighty":-1.93682,"marketCap":406966805},{"date":"2025-02-07","current":-1.291973,"twenty":-3.709695,"median":-3.247782,"eighty":-1.911755,"marketCap":308489544},{"date":"2025-02-14","current":-1.187157,"twenty":-3.703939,"median":-3.22332,"eighty":-1.873019,"marketCap":283462173},{"date":"2025-02-21","current":-1.178042,"twenty":-3.690125,"median":-3.211808,"eighty":-1.829725,"marketCap":281285880},{"date":"2025-02-28","current":-1.059555,"twenty":-3.68437,"median":-3.162882,"eighty":-1.759544,"marketCap":252994070},{"date":"2025-03-07","current":-1.111963,"twenty":-3.676887,"median":-3.070787,"eighty":-1.711693,"marketCap":265507755},{"date":"2025-03-14","current":-1.041326,"twenty":-3.672858,"median":-3.006033,"eighty":-1.678881,"marketCap":248641484},{"date":"2025-03-21","current":-0.693421,"twenty":-3.667968,"median":-2.978693,"eighty":-1.565406,"marketCap":204027476},{"date":"2025-03-28","current":-1.042906,"twenty":-3.659692,"median":-2.965742,"eighty":-1.505251,"marketCap":306857324},{"date":"2025-04-04","current":-1.85837,"twenty":-3.65559,"median":-2.803137,"eighty":-1.500694,"marketCap":546793636},{"date":"2025-04-11","current":-1.198232,"twenty":-3.63199,"median":-2.286587,"eighty":-1.463027,"marketCap":352559478},{"date":"2025-04-17","current":-0.924562,"twenty":-3.622781,"median":-2.176074,"eighty":-1.280365,"marketCap":272036635},{"date":"2025-04-25","current":-0.791425,"twenty":-3.613572,"median":-2.146452,"eighty":-1.183511,"marketCap":232863359},{"date":"2025-05-02","current":-0.848748,"twenty":-3.60871,"median":-2.125945,"eighty":-1.162092,"marketCap":249729630},{"date":"2025-05-09","current":-0.930109,"twenty":-3.590112,"median":-2.016571,"eighty":-1.140673,"marketCap":273668854},{"date":"2025-05-16","current":-0.890525,"twenty":-3.561975,"median":-1.997203,"eighty":-1.105127,"marketCap":305759157},{"date":"2025-05-23","current":-0.766929,"twenty":-3.530406,"median":-1.968721,"eighty":-1.070948,"marketCap":263322832},{"date":"2025-05-30","current":-0.619565,"twenty":-3.51429,"median":-1.964163,"eighty":-1.045883,"marketCap":212725677},{"date":"2025-06-06","current":-0.530829,"twenty":-3.506511,"median":-1.95277,"eighty":-1.037224,"marketCap":182258572},{"date":"2025-06-13","current":-0.503891,"twenty":-3.48667,"median":-1.925427,"eighty":-0.984896,"marketCap":173009629},{"date":"2025-06-20","current":-0.476954,"twenty":-3.466829,"median":-1.916313,"eighty":-0.943233,"marketCap":163760687},{"date":"2025-06-27","current":-0.522906,"twenty":-3.464493,"median":-1.909477,"eighty":-0.920124,"marketCap":179538295},{"date":"2025-07-03","current":-0.538752,"twenty":-3.462191,"median":-1.878715,"eighty":-0.88573,"marketCap":184978849},{"date":"2025-07-11","current":-0.564105,"twenty":-3.459313,"median":-1.85837,"eighty":-0.848748,"marketCap":193683736},{"date":"2025-07-18","current":-0.556182,"twenty":-3.450679,"median":-1.833144,"eighty":-0.808067,"marketCap":190963459},{"date":"2025-07-25","current":-0.611642,"twenty":-3.444923,"median":-1.819538,"eighty":-0.791425,"marketCap":210005399},{"date":"2025-08-01","current":-0.65601,"twenty":-3.444923,"median":-1.768203,"eighty":-0.766929,"marketCap":225238952},{"date":"2025-08-08","current":-1.301335,"twenty":-3.442045,"median":-1.745417,"eighty":-0.761839,"marketCap":446809517},{"date":"2025-08-15","current":-2.007939,"twenty":-3.439167,"median":-1.743138,"eighty":-0.765537,"marketCap":456842285},{"date":"2025-08-22","current":-2.103991,"twenty":-3.427655,"median":-1.761367,"eighty":-0.766929,"marketCap":478695789},{"date":"2025-08-29","current":-2.14973,"twenty":-3.424777,"median":-1.805264,"eighty":-0.766929,"marketCap":489102219},{"date":"2025-09-05","current":-2.103991,"twenty":-3.415567,"median":-1.826307,"eighty":-0.771366,"marketCap":478695789},{"date":"2025-09-12","current":-1.994217,"twenty":-3.40866,"median":-1.836561,"eighty":-0.773109,"marketCap":453720356},{"date":"2025-09-19","current":-1.9622,"twenty":-3.406179,"median":-1.867544,"eighty":-0.787793,"marketCap":446435855},{"date":"2025-09-26","current":-1.824983,"twenty":-3.405847,"median":-1.875296,"eighty":-0.795863,"marketCap":415216564},{"date":"2025-10-03","current":-1.811262,"twenty":-3.397967,"median":-1.860219,"eighty":-0.799931,"marketCap":412094635},{"date":"2025-10-10","current":-2.071974,"twenty":-3.391392,"median":-1.873019,"eighty":-0.803629,"marketCap":471411288},{"date":"2025-10-17","current":-2.108565,"twenty":-3.371823,"median":-1.884428,"eighty":-0.807327,"marketCap":479736432},{"date":"2025-10-24","current":-2.108565,"twenty":-3.341892,"median":-1.893592,"eighty":-0.812505,"marketCap":479736432},{"date":"2025-10-31","current":-2.131434,"twenty":-3.317141,"median":-1.904969,"eighty":-0.82249,"marketCap":484939647},{"date":"2025-11-07","current":-2.158878,"twenty":-3.30563,"median":-1.911755,"eighty":-0.843135,"marketCap":491183505},{"date":"2025-11-14","current":-2.422653,"twenty":-3.301601,"median":-1.918592,"eighty":-0.848547,"marketCap":551197167},{"date":"2025-11-21","current":-2.946741,"twenty":-3.29642,"median":-1.93682,"eighty":-0.86502,"marketCap":722402348},{"date":"2025-11-28","current":-3.266113,"twenty":-3.290089,"median":-1.953052,"eighty":-0.869088,"marketCap":800697401},{"date":"2025-12-05","current":-3.534386,"twenty":-3.297571,"median":-1.962042,"eighty":-0.870197,"marketCap":866465244},{"date":"2025-12-12","current":-4.943882,"twenty":-3.336738,"median":-1.966442,"eighty":-0.879813,"marketCap":1212007408},{"date":"2025-12-19","current":-4.709675,"twenty":-3.399937,"median":-1.972322,"eighty":-0.888607,"marketCap":1154591037},{"date":"2025-12-26","current":-4.854457,"twenty":-3.410963,"median":-1.990368,"eighty":-0.898223,"marketCap":1190084794},{"date":"2026-01-02","current":-4.156097,"twenty":-3.436865,"median":-1.996504,"eighty":-0.911618,"marketCap":1018879613},{"date":"2026-01-09","current":-7.741582,"twenty":-3.449528,"median":-2.003365,"eighty":-0.920124,"marketCap":1897872066},{"date":"2026-01-16","current":-12.290084,"twenty":-3.466829,"median":-2.013154,"eighty":-0.925671,"marketCap":3012950964},{"date":"2026-01-23","current":-13.362987,"twenty":-3.516406,"median":-2.019374,"eighty":-0.930109,"marketCap":3275976472},{"date":"2026-01-30","current":-13.647739,"twenty":-3.577828,"median":-2.030809,"eighty":-0.937506,"marketCap":3345784190},{"date":"2026-02-06","current":-13.393497,"twenty":-3.626234,"median":-2.053678,"eighty":-0.942816,"marketCap":3283455871},{"date":"2026-02-13","current":-13.6274,"twenty":-3.672282,"median":-2.062826,"eighty":-0.944902,"marketCap":3340797925},{"date":"2026-02-20","current":-14.850306,"twenty":-3.690125,"median":-2.071974,"eighty":-0.965612,"marketCap":3640597141},{"date":"2026-02-24","current":-14.059612,"twenty":-3.708544,"median":-2.081121,"eighty":-0.973379,"marketCap":3446756068}],"updateTime":1772085383275},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ALMS\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2600098766","title":"Alumis Inc - Climb Bio Refuses to Pay $3,000,000 Development Milestone Payment Due Jan 1, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2600098766","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600098766?lang=en_us&edition=fundamental","pubTime":"2026-01-03 05:08","pubTimestamp":1767388106,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260102:nFWN3Y30CH:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2600701814","title":"Climb Bio Sues Alumis Over $3 Million Milestone Dispute","url":"https://stock-news.laohu8.com/highlight/detail?id=2600701814","media":"Reuters","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2600701814?lang=en_us&edition=fundamental","pubTime":"2026-01-01 05:13","pubTimestamp":1767215610,"startTime":"0","endTime":"0","summary":"Climb Bio Inc., a Massachusetts-based biotechnology company, has filed a lawsuit seeking resolution of a dispute with Alumis Inc. and its subsidiary Acelyrin Inc. The litigation centers on a January 2024 Asset Purchase Agreement, under which Climb acquired assets related to the drug candidate budoprutug. Climb alleges that despite not receiving any royalty-bearing patents from Alumis or Acelyrin, it was invoiced for a $3 million milestone payment after dosing its first patient in a Phase 2 clinical trial. Climb maintains that its payment obligations are limited to products that would infringe patents included in the transferred assets or filed within nine months of the agreement’s closing, which it claims it did not receive. The company is seeking the court’s intervention to clarify its obligations and resolve the ongoing dispute.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251231:nNDL9hWHb3:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","BK4539","CLYM","ALMS","BK4007"],"gpt_icon":0},{"id":"2593034161","title":"Assessing Alumis (ALMS) Valuation After S&P Pharma Index Inclusion and Reinforced Analyst Optimism","url":"https://stock-news.laohu8.com/highlight/detail?id=2593034161","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593034161?lang=en_us&edition=fundamental","pubTime":"2025-12-22 09:13","pubTimestamp":1766365996,"startTime":"0","endTime":"0","summary":"Alumis (ALMS) just cleared an important milestone: it has been added to the S&P Pharmaceuticals Select Industry Index, a move that can quietly reshape who owns the stock and how it trades.\nSee our latest analysis for Alumis.\nThe index inclusion comes after a powerful run, with a roughly 172 percent 3 month share price return off a base near 11 dollars. This signals building momentum as investors reassess Alumis growth potential and risk profile.\nIf Alumis sprint has you looking at what else...","market":"nz","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/assessing-alumis-alms-valuation-after-sp-pharma-index-inclus","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/assessing-alumis-alms-valuation-after-sp-pharma-index-inclus","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2592423188","title":"Alumis Is Maintained at Buy by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2592423188","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592423188?lang=en_us&edition=fundamental","pubTime":"2025-12-19 00:37","pubTimestamp":1766075820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ALMS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 18, 2025 11:37 ET (16:37 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS"],"gpt_icon":0},{"id":"2590378978","title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2590378978","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590378978?lang=en_us&edition=fundamental","pubTime":"2025-12-10 08:14","pubTimestamp":1765325666,"startTime":"0","endTime":"0","summary":"Srinivas Akkaraju, Director, reported an acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 09, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251210:nNDL8sRF2v:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2589328853","title":"Assessing Alumis (ALMS) Valuation After Director Srinivas Akkaraju’s $2 Million Insider Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=2589328853","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589328853?lang=en_us&edition=fundamental","pubTime":"2025-12-08 18:16","pubTimestamp":1765189003,"startTime":"0","endTime":"0","summary":"Recent filings reveal that Alumis (ALMS) director Srinivas Akkaraju has bought about $2 million of company stock across several days. This purchase is a confidence signal that lands just as the shares gain strong momentum.\nSee our latest analysis for Alumis.\nThe timing of Akkaraju’s buying lines up with powerful momentum, with a 30 day share price return of 135.59 percent and a 90 day share price return of 160.42 percent pushing Alumis to $11.12. At the same time, the 1 year total shareholder...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice2-main-header/1585186699299"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/assessing-alumis-alms-valuation-after-director-srinivas-akka","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-alms/alumis/news/assessing-alumis-alms-valuation-after-director-srinivas-akka","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2589594058","title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2589594058","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2589594058?lang=en_us&edition=fundamental","pubTime":"2025-12-05 09:12","pubTimestamp":1764897132,"startTime":"0","endTime":"0","summary":"Srinivas Akkaraju, Director, reported the acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 04, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251205:nNDL6fXwrp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2588257040","title":"Alumis Inc. unveils late-stage immunology pipeline and key upcoming clinical milestones","url":"https://stock-news.laohu8.com/highlight/detail?id=2588257040","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588257040?lang=en_us&edition=fundamental","pubTime":"2025-12-04 02:27","pubTimestamp":1764786451,"startTime":"0","endTime":"0","summary":"Alumis Inc. has released a corporate presentation highlighting progress in its late-stage precision immunology pipeline. The company's portfolio includes three clinical-stage molecules: Envudeucitinib, a TYK2 inhibitor for psoriasis and systemic lupus erythematosus ; A-005, a CNS-penetrant TYK2 inhibitor for multiple sclerosis and other neuroinflammatory diseases; and Lonigutamab, an anti-IGF-1R therapy for thyroid eye disease. Top-line Phase 3 data for Envudeucitinib in psoriasis are expected in early Q1 2026, with Phase 2b data in SLE anticipated in Q3 2026. The presentation notes that the company had $377.7 million in cash, cash equivalents, and marketable securities as of September 30, 2025, projected to fund operations into 2027. You can access the full presentation through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251203:nNDL7MC5D8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2588709800","title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2588709800","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2588709800?lang=en_us&edition=fundamental","pubTime":"2025-12-02 07:10","pubTimestamp":1764630608,"startTime":"0","endTime":"0","summary":"Srinivas Akkaraju, Director of Alumis Inc., reported the acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on December 01, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251201:nNDL4D1QpV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2586740606","title":"Foresite Capital Management VI LLC Acquires Common Shares of Alumis Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2586740606","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586740606?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:03","pubTimestamp":1764104621,"startTime":"0","endTime":"0","summary":"Foresite Capital Management VI LLC and related entities reported the acquisition of common shares of Alumis Inc. , according to a recent SEC filing. Other reporting beneficial owners include Foresite Capital Management V, LLC and Foresite Capital Fund V, L.P., among others. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDLwzVG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2586406080","title":"Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2586406080","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586406080?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:02","pubTimestamp":1764104571,"startTime":"0","endTime":"0","summary":"James B. Tananbaum, a Director and 10% Owner, reported the acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL7TT1xR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"2586060544","title":"Foresite Labs Reports Acquisition of Alumis Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586060544","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586060544?lang=en_us&edition=fundamental","pubTime":"2025-11-26 05:01","pubTimestamp":1764104509,"startTime":"0","endTime":"0","summary":"Foresite Labs, LLC and Foresite Labs Affiliates 2021, LLC, both significant beneficial owners, have reported the acquisition of common shares of Alumis Inc. Other reporting beneficial owners were also included in the filing. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 25, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251125:nNDL37Zjpp:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","ALMS"],"gpt_icon":0},{"id":"1191343082","title":"Stock Track | Alumis Inc. Soars 13.07% in Pre-market on Wave of Insider and Institutional Share Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=1191343082","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191343082?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:48","pubTimestamp":1763650101,"startTime":"0","endTime":"0","summary":"Alumis Inc. (ALMS) stock is experiencing a significant surge in pre-market trading on Thursday, soaring 13.07% following a series of insider and institutional share acquisitions reported late...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALMS"],"gpt_icon":0},{"id":"1100365093","title":"Stock Track | Alumis Inc. Skyrockets 13.07% Following Significant Insider and Institutional Share Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=1100365093","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1100365093?lang=en_us&edition=fundamental","pubTime":"2025-11-20 22:48","pubTimestamp":1763650100,"startTime":"0","endTime":"0","summary":"Alumis Inc. (ALMS) stock is experiencing a remarkable surge, soaring 13.07% in Thursday's trading session. This significant uptick comes on the heels of multiple insider and institutional share...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALMS"],"gpt_icon":0},{"id":"1194488985","title":"Stock Track | Alumis Inc. Soars 7.61% Pre-market Following Multiple Insider Share Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=1194488985","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1194488985?lang=en_us&edition=fundamental","pubTime":"2025-11-20 19:12","pubTimestamp":1763637144,"startTime":"0","endTime":"0","summary":"Alumis Inc. (ALMS) stock is surging in pre-market trading, jumping 7.61% following a series of insider share acquisitions reported late Wednesday. The significant uptick in stock price comes as...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALMS"],"gpt_icon":0},{"id":"1168540877","title":"Stock Track | Alumis Inc. Soars 7.61% Pre-market on Multiple Insider and Institutional Share Acquisitions","url":"https://stock-news.laohu8.com/highlight/detail?id=1168540877","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168540877?lang=en_us&edition=fundamental","pubTime":"2025-11-20 19:12","pubTimestamp":1763637141,"startTime":"0","endTime":"0","summary":"Alumis Inc. (ALMS) stock is experiencing a significant pre-market surge, jumping 7.61% in Thursday's early trading. This notable increase comes on the heels of multiple insider and institutional...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ALMS"],"gpt_icon":0},{"id":"2584924903","title":"Foresite Labs LLC Reports Acquisition of Common Shares of Alumis Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2584924903","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584924903?lang=en_us&edition=fundamental","pubTime":"2025-11-20 09:54","pubTimestamp":1763603686,"startTime":"0","endTime":"0","summary":"Foresite Labs, LLC, a beneficial owner, reported the acquisition of common shares of Alumis Inc. , according to a recent SEC filing. The form was filed by more than one reporting person, including Foresite Labs, LLC and other reporting beneficial owners. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDLc3SWhF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2584943903","title":"Director and 10% Owner James B. Tananbaum Acquires Common Shares of Alumis Inc","url":"https://stock-news.laohu8.com/highlight/detail?id=2584943903","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584943903?lang=en_us&edition=fundamental","pubTime":"2025-11-20 09:51","pubTimestamp":1763603511,"startTime":"0","endTime":"0","summary":"James B. Tananbaum, a Director and 10% Owner, reported the acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDLbDK4py:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2584903641","title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2584903641","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584903641?lang=en_us&edition=fundamental","pubTime":"2025-11-20 09:47","pubTimestamp":1763603221,"startTime":"0","endTime":"0","summary":"Srinivas Akkaraju, a Director at Alumis Inc., has reported the acquisition of common shares of Alumis Inc. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alumis Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251120:nNDL53CjdK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Alumis Inc. Director Srinivas Akkaraju Reports Acquisition of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0},{"id":"2584092218","title":"Alumis Q3 Operating Expenses USD 117.358 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2584092218","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584092218?lang=en_us&edition=fundamental","pubTime":"2025-11-20 01:41","pubTimestamp":1763574076,"startTime":"0","endTime":"0","summary":"Nov 13 (Reuters) - Alumis Q3 income from operations USD -115.292 million.:  ((Reuters Investor Briefs; email: reutersinvestor.briefs@thomsonreuters.com))  Source Date/Time = 13-NOV-202521:15:47.297 GMT","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nRSD7BmcW2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ALMS","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":93,"code":"91000000","status":"200"}]}}